CAS 1204572-55-3

BPAM344

CAS : 1204572-55-3

Formule : C₁₀H₁₁FN₂O₂S

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 242.2699

Ref: IN-DA01X5O2

4-Cyclopropyl-7-Fluoro-3,4-Dihydro-2H-Benzo[E][1,2,4]Thiadiazine 1,1-Dioxide

CAS : 1204572-55-3

4-Cyclopropyl-7-Fluoro-3,4-Dihydro-2H-Benzo[E][1,2,4]Thiadiazine 1,1-Dioxide

Degré de pureté : 98%

Masse moléculaire : 242.27g/mol

Ref: 54-PC105253

BPAM344

CAS : 1204572-55-3

BPAM344

Degré de pureté : ≥98%

Masse moléculaire : 242.27g/mol

Ref: 54-BUP09648

BPAM344

CAS : 1204572-55-3

BPAM344 is a potent positive allosteric modulator (PAM) of the KAR subunits GluK1b, GluK2a, and GluK3a.

Formule : C₁₀H₁₁FN₂O₂S

Degré de pureté : 99.53%

Couleur et forme : Solid

Masse moléculaire : 242.27

Ref: TM-T9177

BPAM-344

CAS : 1204572-55-3

BPAM-344 is a new class of agent that has been developed for the treatment of Alzheimer's disease. It has shown low toxicity and good pharmacokinetics in animal studies. BPAM-344 is an ionotropic glutamate receptor antagonist that prevents glutamate from binding to the receptor and activating it. This agent also has the ability to block or prevent the development of tolerance to low doses of x-ray radiation, which may be due to its ability to inhibit structural changes in DNA caused by radiation exposure. The structural analysis of this drug revealed a novel molecular scaffold that is different from other agents in its class. A fluorescence assay confirmed that BPAM-344 binds tightly with aluminum oxide, which may be used as a potential adjuvant for this drug.

Formule : C₁₀H₁₁FN₂O₂S

Degré de pureté : Min. 95%

Masse moléculaire : 242.27 g/mol

Ref: 3D-EYB57255